ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.226,82
-0,22%
S&P 500
5.308,15
1,17%
US Dollar vs BRL
5,136
0,13%
Bitcoin
65.859,19
7,01%
Brent Oil
82,72
0,21%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Amylin Pharmaceuticals, Inc. (MM) (AMLN)

  7. Amylin Pharmaceuticals, Inc. (MM) (AMLN) Notícias

AMLN

Amylin Pharmaceuticals, Inc. (MM) (AMLN)

Amylin Pharmaceuticals, Inc. (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMLN
DataHoraFonteTítuloCódigoCompanhia
09/08/201209:24Dow Jones NewsAstraZeneca: Bristol-Myers Squibb Completes Purchase of AmylinNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201217:11Edgar (US Regulatory)(25-NSE)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201210:19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201209:40Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
03/08/201217:26Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201219:03Dow Jones News2nd UPDATE: Bristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201215:00Dow Jones NewsUPDATE: Bristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201213:30Dow Jones NewsBristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201213:17Dow Jones NewsU.S. Charges Bristol-Myers Executive With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201212:07Dow Jones NewsBristol-Myers Pension Executive Robert Ramnarine Arrested for Alleged Insider Trading -BloombergNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
01/08/201208:30Business WireBristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
31/07/201214:32ZacksSolid Quarter at ALKS, View Backed - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
30/07/201217:23Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
26/07/201221:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
26/07/201211:24Dow Jones NewsEvercore 2nd-Quarter Profit Climbs 19% On Higher Investment Banking RevenueNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201209:20Dow Jones NewsBristol-Myers Profit Falls 28%NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201209:00Dow Jones NewsBristol-Myers 2nd-Quarter Profit Falls 28% on Drug-Patent ExpirationsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201206:39ZacksGeneric Plavix Hurts Bristol-Myers - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
23/07/201210:30ZacksEarnings Preview: Bristol-Myers - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
17/07/201215:10ZacksTPG to Acquire Par Pharma for $1.9B - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
12/07/201216:05Dow Jones NewsUPDATE: Icahn Appeals to Nonmanagement Directors at Forest LabsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
11/07/201219:10Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
11/07/201214:03ZacksBristol-Myers/AMLN Deal Progresses - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201213:01PR Newswire (US)Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201209:06Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201208:30Business WireBristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201206:15ZacksAlkermes Upped to Outperform - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
09/07/201213:51PR Newswire (US)Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
07/07/201210:00Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
06/07/201209:53Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMLN

Seu Histórico Recente

COIN
AIDEUR
AidCoin
AQSE
MTC.GB
Mothercare
BIT
P1HZN6
BNP Paribas Issuance
AMEX
SJG
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados